Effectiveness of anti-clotting meds after stent placement varied in people with diabetes
One year of dual antiplatelet therapy with one of two potent P2Y12 inhibitors—ticagrelor or prasugrel—in people with Type 1 or Type 2 diabetes who had received a drug-eluting stent did not offer the same level of benefit ...
Nov 10, 2025
0
15
